Undermethylation may represent one contributing or modifying pattern in a subgroup of patients
Sarfraz, I., Rasul, A., Hussain, G., Shah, M
Each consultation includes a review of medical history, medications, wellness goals, risk factors, and treatment eligibility
Conclusion GLP-1A was conjugated with oligomeric DOCAs, and the resulting chimeric compound showed the potential not only for glucagon-like peptide-1 receptor agonist activity but also for oral delivery
Exenatide through PPAR improved hepatic insulin resistance in patients of type 2 diabetes mellitus via suppressing pyroptosis